JPWO2020076614A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020076614A5
JPWO2020076614A5 JP2021543981A JP2021543981A JPWO2020076614A5 JP WO2020076614 A5 JPWO2020076614 A5 JP WO2020076614A5 JP 2021543981 A JP2021543981 A JP 2021543981A JP 2021543981 A JP2021543981 A JP 2021543981A JP WO2020076614 A5 JPWO2020076614 A5 JP WO2020076614A5
Authority
JP
Japan
Prior art keywords
expression construct
composition
artificial expression
injection
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021543981A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513339A (ja
JP2022513339A5 (https=
JP7695192B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/054539 external-priority patent/WO2020076614A1/en
Publication of JP2022513339A publication Critical patent/JP2022513339A/ja
Publication of JPWO2020076614A5 publication Critical patent/JPWO2020076614A5/ja
Publication of JP2022513339A5 publication Critical patent/JP2022513339A5/ja
Priority to JP2024187194A priority Critical patent/JP7829658B2/ja
Application granted granted Critical
Publication of JP7695192B2 publication Critical patent/JP7695192B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021543981A 2018-10-08 2019-10-03 介在ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物 Active JP7695192B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024187194A JP7829658B2 (ja) 2018-10-08 2024-10-24 介在ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862742835P 2018-10-08 2018-10-08
US62/742,835 2018-10-08
US201862749012P 2018-10-22 2018-10-22
US62/749,012 2018-10-22
US201962810281P 2019-02-25 2019-02-25
US62/810,281 2019-02-25
PCT/US2019/054539 WO2020076614A1 (en) 2018-10-08 2019-10-03 Artificial expression constructs for selectively modulating gene expression in interneurons

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024187194A Division JP7829658B2 (ja) 2018-10-08 2024-10-24 介在ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物

Publications (4)

Publication Number Publication Date
JP2022513339A JP2022513339A (ja) 2022-02-07
JPWO2020076614A5 true JPWO2020076614A5 (https=) 2022-10-11
JP2022513339A5 JP2022513339A5 (https=) 2022-10-11
JP7695192B2 JP7695192B2 (ja) 2025-06-18

Family

ID=70164665

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021543981A Active JP7695192B2 (ja) 2018-10-08 2019-10-03 介在ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物
JP2024187194A Active JP7829658B2 (ja) 2018-10-08 2024-10-24 介在ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024187194A Active JP7829658B2 (ja) 2018-10-08 2024-10-24 介在ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物

Country Status (6)

Country Link
US (2) US12467064B2 (https=)
EP (1) EP3864150A4 (https=)
JP (2) JP7695192B2 (https=)
AU (2) AU2019358806B2 (https=)
CA (1) CA3115652A1 (https=)
WO (1) WO2020076614A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019253700B2 (en) 2018-04-09 2025-08-14 Allen Institute Rescuing voltage-gated sodium channel function in inhibitory neurons
JP7695192B2 (ja) * 2018-10-08 2025-06-18 アレン インスティテュート 介在ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物
US20230159952A1 (en) * 2020-04-21 2023-05-25 Allen Institute Artificial expression constructs for selectively modulating gene expression in neocortical layer 5 glutamatergic neurons
EP4162041A4 (en) * 2020-06-04 2024-10-16 Allen Institute ARTIFICIAL EXPRESSION CONSTRUCTS TO SELECTIVELY MODULATE GENE EXPRESSION IN INHIBITORY NEOCORTICAL NEURONS
WO2022036255A1 (en) * 2020-08-14 2022-02-17 Allen Institute Artificial expression constructs for modulating gene expression in striatal neurons
GB202013940D0 (en) 2020-09-04 2020-10-21 Synpromics Ltd Regulatory nucleic acid sequences
CA3207224A1 (en) * 2021-02-02 2022-08-11 Bryan GORE Artificial expression constructs for modulating gene expression in gabaergic neurons and astrocytes
CN116286917A (zh) * 2021-12-14 2023-06-23 中国科学院深圳先进技术研究院 重组载体及其构建方法和应用
JP2025520385A (ja) * 2022-06-13 2025-07-03 アレン インスティテュート 中枢神経系の非神経細胞において遺伝子発現を調節するための人工発現コンストラクト
JP2025525378A (ja) * 2022-06-21 2025-08-05 リーゲル セラピューティクス,インコーポレイティッド 遺伝子調節エレメント及びその使用
CN119060958A (zh) * 2023-12-15 2024-12-03 中国科学院深圳先进技术研究院 一种携带钙离子报告基因的神经元及其制备方法和应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2002A (en) 1841-03-12 Tor and planter for plowing
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
US5252334A (en) 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5851832A (en) 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
US5766948A (en) 1993-01-06 1998-06-16 The Regents Of The University Of California Method for production of neuroblasts
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
US6001654A (en) 1994-01-28 1999-12-14 California Institute Of Technology Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors
US5697899A (en) 1995-02-07 1997-12-16 Gensia Feedback controlled drug delivery system
IE80468B1 (en) 1995-04-04 1998-07-29 Elan Corp Plc Controlled release biodegradable nanoparticles containing insulin
US6048964A (en) 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US5656016A (en) 1996-03-18 1997-08-12 Abbott Laboratories Sonophoretic drug delivery system
US5753506A (en) 1996-05-23 1998-05-19 Cns Stem Cell Technology, Inc. Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals
US5797898A (en) 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
US5783208A (en) 1996-07-19 1998-07-21 Theratech, Inc. Transdermal drug delivery matrix for coadministering estradiol and another steroid
US5779708A (en) 1996-08-15 1998-07-14 Cyberdent, Inc. Intraosseous drug delivery device and method
US5968829A (en) 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
WO2001036623A2 (en) * 1999-11-05 2001-05-25 Avigen, Inc. Ecdysone-inducible adeno-associated virus expression vectors
US6395546B1 (en) 2000-02-01 2002-05-28 Neurogeneration, Inc. Generation of dopaminergic neurons from human nervous system stem cells
WO2002064804A2 (en) 2001-02-13 2002-08-22 University Of Florida A bi-directional dual promoter complex with enhanced promoter activity for transgene expression in eukaryotes
JP4906231B2 (ja) 2001-09-14 2012-03-28 ステム セル セラピューティクス インコーポレイテッド プロラクチン誘導性の神経幹細胞数の増加ならびにその治療用途
WO2003072751A2 (en) 2002-02-25 2003-09-04 Vanderbilt University Expression system for human brain-specific voltage-gated sodium channel, type 1
WO2009012176A2 (en) 2007-07-14 2009-01-22 The University Of Iowa Research Foundation Methods and compositions for treating brain diseases
US20120308530A1 (en) 2011-06-03 2012-12-06 Beijing Allgens Medical Science & Technology Co., Ltd. Materials Composition and Methods to Control Neural Progenitor and Stem Cell Attachment, Proliferation and Guide Cell Differentiation
WO2013142337A1 (en) 2012-03-20 2013-09-26 The Trustees Of The University Of Pennsylvania Human papillomavirus 16 (hpv16) - related epilepsy
EP2888368A1 (en) 2012-08-27 2015-07-01 Friedrich Miescher Institute for Biomedical Research Retinal off circuit-specific promoter
DE102014207498A1 (de) 2014-04-17 2015-10-22 Universitätsklinikum Hamburg-Eppendorf Viraler Vektor für den zielgerichteten Gentransfer in Gehirn und Rückenmark
WO2016161124A1 (en) * 2015-03-31 2016-10-06 New York University Compositions and method for reducing seizures
DK3081263T3 (da) 2015-04-17 2020-03-16 P&X Medical Nv Sammensætninger og redskaber til behandling af glaukom
WO2016186772A2 (en) 2015-05-16 2016-11-24 Genzyme Corporation Gene editing of deep intronic mutations
KR102423442B1 (ko) 2015-12-11 2022-07-20 캘리포니아 인스티튜트 오브 테크놀로지 아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드
EA201992358A1 (ru) * 2017-04-03 2020-03-24 Инкоудид Терапьютикс, Инк. Тканеселективная экспрессия трансгена
US11980671B2 (en) 2017-07-26 2024-05-14 Duke University Use of bacterial voltage gated ion channels for human therapies
AU2019253700B2 (en) 2018-04-09 2025-08-14 Allen Institute Rescuing voltage-gated sodium channel function in inhibitory neurons
JP7695192B2 (ja) 2018-10-08 2025-06-18 アレン インスティテュート 介在ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物

Similar Documents

Publication Publication Date Title
JP2025023947A5 (https=)
JP7590962B2 (ja) 皮質興奮性ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物
JP2026021360A5 (https=)
JPWO2020076614A5 (https=)
Nathanson et al. Short promoters in viral vectors drive selective expression in mammalian inhibitory neurons, but do not restrict activity to specific inhibitory cell-types
US20230048025A1 (en) Adeno associated viral vectors
CN116096394A (zh) 用于治疗心脏病的基因疗法载体
CA2382832A1 (en) Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
CN109661470A (zh) 新型aav8突变衣壳和含有其的组合物
US6872869B2 (en) Method for establishing an expression system of spider dragline silk gene in bombyx mori
CN102741405A (zh) 提高基因表达的系统和保持有该系统的载体
CN114072179A (zh) 肌球蛋白15启动子及其用途
JP4701336B2 (ja) ヒト・コラーゲンを産生する形質転換カイコ
TW202142554A (zh) 腺相關病毒蛋白殼多肽及載體
US20260109978A1 (en) Nucleic acid regulatory elements for constitutive gene expression and methods of use
KR20210143855A (ko) 세포-유형별 특이적 조절 요소들을 식별해내기 위한 조절 요소들의 멀티플렉싱
CN101410517A (zh) 用于在蚕中制备重组蛋白质的多聚核苷酸
CN112725342A (zh) 一种启动子pCALM2及其应用
CN108642059A (zh) 适用于家蚕表达的改造具有促进细胞增殖因子基因及其表达载体和应用
US12472270B2 (en) Methods and compositions for reprogramming Müller Glia
Guo et al. Silk gland specific secretory expression of egfp gene in silkworm Bombyx mori with rAcMNPV system
US20250213729A1 (en) Method to stimulate regeneration of retinal ganglion cells
JPWO2021248085A5 (https=)
CN120153066A (zh) 类器官中筛选aav病毒颗粒库的方法
WO2021248085A4 (en) Artificial expression constructs for selectively modulating gene expression in inhibitory neocortical neurons